Does methotrexate treatment for ectopic pregnancy influence the patient's performance during a subsequent in vitro fertilization/embryo transfer cycle?

Raoul Orvieto*, Jenya Kruchkovich, Efraim Zohav, Jacob Rabinson, Eyal Y. Anteby, Simion Meltcer

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

In a study on the influence of methotrexate (MTX) treatment on ovarian stimulation characteristics during the subsequent IVF cycle, 14 patients admitted to our department with the diagnosis of ectopic pregnancy and successfully treated with MTX were evaluated. No differences were observed in ovarian stimulation characteristics between the IVF cycle that had resulted in the ectopic pregnancy and the IVF cycle that followed MTX treatment. Treating ectopic pregnancy with MTX has no influence on patients' performance in the following IVF cycle.

Original languageEnglish
Pages (from-to)1685-1686
Number of pages2
JournalFertility and Sterility
Volume88
Issue number6
DOIs
StatePublished - Dec 2007
Externally publishedYes

Fingerprint

Dive into the research topics of 'Does methotrexate treatment for ectopic pregnancy influence the patient's performance during a subsequent in vitro fertilization/embryo transfer cycle?'. Together they form a unique fingerprint.

Cite this